the growth is already priced into the mkt price (hence the 1.5-1.6 valuation). The P&L loss is blowing out though ... probably driving the downward impact on price today.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025